Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2008 Filed Dec 16, 2008 18:25 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-08-000096 · edgar.xml · derivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 2,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| December 15, 2008 Filed Dec 16, 2008 18:25 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 2,400 | $25.81 | $61,944.00 |
DisclosureSEC source: 0000875320-08-000096 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,390 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Read SEC document |
| December 15, 2008 Filed Dec 16, 2008 18:25 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.07 | $21,768.00 |
DisclosureSEC source: 0000875320-08-000096 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2008 Filed Dec 12, 2008 16:02 UTC |
Lewis-Hall Freda CEVP, Medicines Development
|
SaleCommon Stock | 1,098 | $26.00 | $28,548.00 |
DisclosureSEC source: 0000875320-08-000094 · edgar.xml · nonDerivative · entry 2 Lewis-Hall Freda C · CIK 0001437909 · EVP, Medicines Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · kind: Transaction made pursuant to Dr. Lewis-Hall's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 10, 2008 Filed Dec 12, 2008 16:02 UTC |
Lewis-Hall Freda CEVP, Medicines Development
|
SaleCommon Stock | 152 | $26.00 | $3,952.00 |
DisclosureSEC source: 0000875320-08-000094 · edgar.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · EVP, Medicines Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,848 F1 · kind: Transaction made pursuant to Dr. Lewis-Hall's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 20:01 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000093 · edgar.xml · derivative · entry 7 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 20:01 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 300 | $23.48 | $7,044.00 |
DisclosureSEC source: 0000875320-08-000093 · edgar.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $23.48 (range $23.44 to $23.51). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 20:01 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 8,200 | $22.96 | $188,272.00 |
DisclosureSEC source: 0000875320-08-000093 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,344 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $22.96 (range $22.45 to $23.43). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 20:01 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 3,500 | $22.12 | $77,420.00 |
DisclosureSEC source: 0000875320-08-000093 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103,544 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $22.12 (range $21.43 to $22.39). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 20:01 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,000 | $13.63 | $163,560.00 |
DisclosureSEC source: 0000875320-08-000093 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2008 Filed Dec 1, 2008 20:11 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000092 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 26, 2008 Filed Dec 1, 2008 20:11 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 13,000 | $24.33 | $316,290.00 |
DisclosureSEC source: 0000875320-08-000092 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $24.33 (range $24.05 to $24.69). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 26, 2008 Filed Dec 1, 2008 20:11 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000092 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2008 Filed Nov 20, 2008 20:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 1,900 | $26.87 | $51,053.00 |
DisclosureSEC source: 0000875320-08-000091 · edgar.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F5 · price: Open market sales reported on this line occurred at a weighted average price of $26.87 (range $26.60 to $27.09). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2008 Filed Nov 20, 2008 20:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 1,400 | $26.18 | $36,652.00 |
DisclosureSEC source: 0000875320-08-000091 · edgar.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,944 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $26.18 (range $25.55 to $26.51). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2008 Filed Nov 20, 2008 20:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 1,100 | $25.07 | $27,577.00 |
DisclosureSEC source: 0000875320-08-000091 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,344 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $25.07 (range $24.44 to $25.44). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2008 Filed Nov 20, 2008 20:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 8,600 | $23.72 | $203,992.00 |
DisclosureSEC source: 0000875320-08-000091 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,444 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $23.72 (range $23.37 to $24.29). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2008 Filed Nov 20, 2008 20:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000091 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 17:31 UTC |
BOGER KENNETH SSVP & General Counsel
|
SaleCommon Stock | 15,000 | $26.69 | $400,350.00 |
DisclosureSEC source: 0000875320-08-000085 · edgar.xml · nonDerivative · entry 1 BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,517 F1 · price: Open market sales reported on this line occurred at a wieghted average price of $26.69 (range $26.60 to $26.82). F2 · price: Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 21:22 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 379 | $26.10 | $9,891.90 |
DisclosureSEC source: 0000875320-08-000086 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,164 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $26.10 (range $25.75 to $26.53). F3 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 21:24 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 86 | $26.12 | $2,246.32 |
DisclosureSEC source: 0000875320-08-000087 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,282 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $26.12 (range $25.70 to $26.53). F3 · price: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 21:26 UTC |
Sachdev AmitSVP, Public Policy,Gov Affairs
|
SaleCommon Stock | 791 | $26.20 | $20,724.20 |
DisclosureSEC source: 0000875320-08-000088 · edgar.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Public Policy,Gov Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,166 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $26.20 (range $25.75 to $26.53). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 21:27 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 16 | $26.18 | $418.88 |
DisclosureSEC source: 0000875320-08-000089 · edgar.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,301 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.18 (range $25.73 to $26.53). F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2008 Filed Nov 19, 2008 21:29 UTC |
Silva Paul MV.P. and Corporate Controller
|
SaleCommon Stock | 218 | $26.13 | $5,696.34 |
DisclosureSEC source: 0000875320-08-000090 · edgar.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · V.P. and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $26.13 (range $25.75 to $26.53). F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 17, 2008 Filed Nov 19, 2008 17:28 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-08-000084 · edgar.xml · derivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 2,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| November 17, 2008 Filed Nov 19, 2008 17:28 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 2,400 | $27.14 | $65,136.00 |
DisclosureSEC source: 0000875320-08-000084 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,390 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $27.14 (range $26.85 to $27.49). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 17, 2008 Filed Nov 19, 2008 17:28 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.07 | $21,768.00 |
DisclosureSEC source: 0000875320-08-000084 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2008 Filed Nov 13, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000083 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 12, 2008 Filed Nov 13, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 13,000 | $26.77 | $348,010.00 |
DisclosureSEC source: 0000875320-08-000083 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.77 (range $26.50 to $27.02). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 12, 2008 Filed Nov 13, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000083 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2008 Filed Nov 6, 2008 19:19 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000082 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| November 05, 2008 Filed Nov 6, 2008 19:19 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 4,100 | $28.37 | $116,317.00 |
DisclosureSEC source: 0000875320-08-000082 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $28.37 (range $28.00 to $28.66). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2008 Filed Nov 6, 2008 19:19 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 8,900 | $27.57 | $245,373.00 |
DisclosureSEC source: 0000875320-08-000082 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,144 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $27.57 (range $27.21 to $27.98). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2008 Filed Nov 6, 2008 19:19 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000082 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2008 Filed Nov 20, 2008 20:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000091 · edgar.xml · derivative · entry 8 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| October 29, 2008 Filed Oct 30, 2008 17:38 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000081 · edgar.xml · derivative · entry 8 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| October 29, 2008 Filed Oct 30, 2008 17:38 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 600 | $23.35 | $14,010.00 |
DisclosureSEC source: 0000875320-08-000081 · edgar.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F5 · price: Open market sales reported on this line occurred at a weighted average price of $23.35 (range $23.23 to $23.59). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 29, 2008 Filed Oct 30, 2008 17:38 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 6,900 | $22.53 | $155,457.00 |
DisclosureSEC source: 0000875320-08-000081 · edgar.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,644 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $22.53 (range $22.03 to $22.97). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 29, 2008 Filed Oct 30, 2008 17:38 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 3,200 | $21.34 | $68,288.00 |
DisclosureSEC source: 0000875320-08-000081 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,544 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $21.34 (range $20.95 to $21.90). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 29, 2008 Filed Oct 30, 2008 17:38 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 2,300 | $20.62 | $47,426.00 |
DisclosureSEC source: 0000875320-08-000081 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105,744 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $20.62 (range $19.96 to $20.93). F6 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 29, 2008 Filed Oct 30, 2008 17:38 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000081 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2008 Filed Oct 23, 2008 18:12 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000080 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| October 22, 2008 Filed Oct 23, 2008 18:12 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 5,600 | $22.88 | $128,128.00 |
DisclosureSEC source: 0000875320-08-000080 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,444 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $22.88 (range $22.50 to $23.48). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 22, 2008 Filed Oct 23, 2008 18:12 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000080 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2008 Filed Oct 22, 2008 18:32 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 485 | $25.65 | $12,440.25 |
DisclosureSEC source: 0000875320-08-000079 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,164 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $25.65 (range $25.27 to $25.97). F3 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 13,000 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000077 · edgar.xml · derivative · entry 7 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 13,000 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 5,300 | $27.41 | $145,273.00 |
DisclosureSEC source: 0000875320-08-000077 · edgar.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $27.41 (range $26.97 to $27.91). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 2,700 | $26.48 | $71,496.00 |
DisclosureSEC source: 0000875320-08-000077 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,344 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $26.48 (range $25.96 to $26.90). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 5,000 | $25.45 | $127,250.00 |
DisclosureSEC source: 0000875320-08-000077 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $25.45 (range $24.79 to $25.78). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:26 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,000 | $13.63 | $177,190.00 |
DisclosureSEC source: 0000875320-08-000077 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,108,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.